vs
Foghorn Therapeutics Inc.（FHTX）与Ready Capital Corp（RC）财务数据对比。点击上方公司名可切换其他公司
Ready Capital Corp的季度营收约是Foghorn Therapeutics Inc.的1.4倍（$13.1M vs $9.2M），Foghorn Therapeutics Inc.净利率更高（-234.3% vs -1772.7%，领先1538.4%），Foghorn Therapeutics Inc.同比增速更快（223.8% vs -73.8%），过去两年Foghorn Therapeutics Inc.的营收复合增速更高（35.3% vs -48.0%）
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
Ready Capital Corp是一家总部位于美国的商业地产金融企业，提供多户住宅贷款、小型商业地产抵押贷款、建筑融资及抵押贷款服务等定制化解决方案，核心客户覆盖美国各地的房地产投资者、小型企业运营者及地产开发商。
FHTX vs RC — 直观对比
营收规模更大
RC
是对方的1.4倍
$9.2M
营收增速更快
FHTX
高出297.6%
-73.8%
净利率更高
FHTX
高出1538.4%
-1772.7%
两年增速更快
FHTX
近两年复合增速
-48.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.2M | $13.1M |
| 净利润 | $-21.7M | $-232.6M |
| 毛利率 | — | — |
| 营业利润率 | -258.2% | -2013.3% |
| 净利率 | -234.3% | -1772.7% |
| 营收同比 | 223.8% | -73.8% |
| 净利润同比 | -11.1% | 26.1% |
| 每股收益（稀释后） | $-0.35 | $-1.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FHTXRC
| Q4 25 | $9.2M | $13.1M | ||
| Q3 25 | $8.2M | $85.4M | ||
| Q2 25 | $7.6M | $16.9M | ||
| Q1 25 | $6.0M | $40.2M | ||
| Q4 24 | $2.9M | $50.1M | ||
| Q3 24 | $7.8M | $107.2M | ||
| Q2 24 | $6.9M | $51.0M | ||
| Q1 24 | $5.0M | $48.5M |
净利润FHTXRC
| Q4 25 | $-21.7M | $-232.6M | ||
| Q3 25 | $-15.8M | $-16.7M | ||
| Q2 25 | $-17.9M | $-53.7M | ||
| Q1 25 | $-18.8M | $82.0M | ||
| Q4 24 | $-19.5M | $-314.8M | ||
| Q3 24 | $-19.1M | $-7.3M | ||
| Q2 24 | $-23.0M | $-34.2M | ||
| Q1 24 | $-25.0M | $-74.2M |
营业利润率FHTXRC
| Q4 25 | -258.2% | -2013.3% | ||
| Q3 25 | -226.9% | -31.5% | ||
| Q2 25 | -279.2% | -524.9% | ||
| Q1 25 | -385.0% | — | ||
| Q4 24 | -840.5% | -629.0% | ||
| Q3 24 | -305.5% | -14.8% | ||
| Q2 24 | -386.6% | -157.0% | ||
| Q1 24 | -558.3% | -217.9% |
净利率FHTXRC
| Q4 25 | -234.3% | -1772.7% | ||
| Q3 25 | -194.4% | -19.6% | ||
| Q2 25 | -237.3% | -317.7% | ||
| Q1 25 | -316.4% | 203.7% | ||
| Q4 24 | -682.9% | -628.8% | ||
| Q3 24 | -244.9% | -6.8% | ||
| Q2 24 | -333.6% | -67.1% | ||
| Q1 24 | -495.4% | -152.8% |
每股收益（稀释后）FHTXRC
| Q4 25 | $-0.35 | $-1.43 | ||
| Q3 25 | $-0.25 | $-0.13 | ||
| Q2 25 | $-0.28 | $-0.34 | ||
| Q1 25 | $-0.30 | $0.46 | ||
| Q4 24 | $-0.23 | $-1.89 | ||
| Q3 24 | $-0.31 | $-0.07 | ||
| Q2 24 | $-0.45 | $-0.23 | ||
| Q1 24 | $-0.59 | $-0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.9M | $207.8M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $-108.5M | $1.5B |
| 总资产 | $198.1M | $7.8B |
| 负债/权益比越低杠杆越低 | — | 0.89× |
8季度趋势，按日历期对齐
现金及短期投资FHTXRC
| Q4 25 | $80.9M | $207.8M | ||
| Q3 25 | $89.3M | $147.5M | ||
| Q2 25 | $72.6M | $162.9M | ||
| Q1 25 | $61.0M | $205.9M | ||
| Q4 24 | $55.5M | $143.8M | ||
| Q3 24 | $57.7M | $181.3M | ||
| Q2 24 | $138.9M | $226.3M | ||
| Q1 24 | $79.3M | $166.0M |
总债务FHTXRC
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.1B |
股东权益FHTXRC
| Q4 25 | $-108.5M | $1.5B | ||
| Q3 25 | $-89.7M | $1.8B | ||
| Q2 25 | $-76.7M | $1.8B | ||
| Q1 25 | $-61.7M | $1.9B | ||
| Q4 24 | $-45.5M | $1.8B | ||
| Q3 24 | $-28.3M | $2.2B | ||
| Q2 24 | $-14.3M | $2.3B | ||
| Q1 24 | $-97.5M | $2.4B |
总资产FHTXRC
| Q4 25 | $198.1M | $7.8B | ||
| Q3 25 | $205.0M | $8.3B | ||
| Q2 25 | $226.2M | $9.3B | ||
| Q1 25 | $258.7M | $10.0B | ||
| Q4 24 | $284.0M | $10.1B | ||
| Q3 24 | $308.4M | $11.3B | ||
| Q2 24 | $328.6M | $11.8B | ||
| Q1 24 | $255.0M | $12.0B |
负债/权益比FHTXRC
| Q4 25 | — | 0.89× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.76× | ||
| Q1 25 | — | 0.77× | ||
| Q4 24 | — | 0.73× | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | 0.52× | ||
| Q1 24 | — | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.3M | $432.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FHTXRC
| Q4 25 | $-22.3M | $432.1M | ||
| Q3 25 | $-18.9M | $434.7M | ||
| Q2 25 | $-21.0M | $-100.3M | ||
| Q1 25 | $-24.0M | $108.5M | ||
| Q4 24 | $-24.5M | $274.8M | ||
| Q3 24 | $-21.0M | $221.1M | ||
| Q2 24 | $-25.5M | $1.1M | ||
| Q1 24 | $-29.3M | $23.4M |
自由现金流FHTXRC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-21.0M | — | ||
| Q1 25 | $-24.0M | — | ||
| Q4 24 | $-25.0M | — | ||
| Q3 24 | $-21.3M | — | ||
| Q2 24 | $-25.6M | — | ||
| Q1 24 | $-29.4M | — |
自由现金流率FHTXRC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -278.2% | — | ||
| Q1 25 | -403.2% | — | ||
| Q4 24 | -875.3% | — | ||
| Q3 24 | -273.0% | — | ||
| Q2 24 | -371.0% | — | ||
| Q1 24 | -583.1% | — |
资本支出强度FHTXRC
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 2.0% | — |
现金转化率FHTXRC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.32× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
